• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[硬化性黏液水肿的临床特征及转归:一项回顾性多中心研究]

[Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study].

作者信息

Le Moigne M, Mazereeuw-Hautier J, Bonnetblanc J-M, Astudillo L, D'Incan M, Bessis D, Thomas L, Debarbieux S, Ammoury A, Lamant L, Paul C

机构信息

Dermatologie, CHU de Toulouse, Université Paul-Sabatier, Toulouse, France.

出版信息

Ann Dermatol Venereol. 2010 Dec;137(12):782-8. doi: 10.1016/j.annder.2010.08.011. Epub 2010 Sep 28.

DOI:10.1016/j.annder.2010.08.011
PMID:21134580
Abstract

BACKGROUND

scleromyxoedema is characterized by dermal mucin deposition associated with a monoclonal gammopathy. This is a rare disease, mostly reported as isolated cases. There is limited data regarding the course and prognosis of the disease. The aim of this study was to determine the clinical characteristics and course of scleromyxoedema.

PATIENTS AND METHODS

this was a retrospective study in patients from five French university hospitals between 1987 and 2007. Data were collected using a standardized questionnaire. The inclusion criteria were based on the disease diagnosis criteria proposed by Rongioletti and Rebora: (1) generalized, papular and sclerodermiform skin eruption, (2) mucin deposition in the dermis, fibroblastic proliferation and skin fibrosis, (3) presence of a monoclonal gammopathy, (4) absence of thyroid disease.

RESULTS

eight patients were included. The mean age at disease onset was 51.5 years (range: 35-67). The mean time from primary symptoms and diagnosis was 41.6 months (range: 4-120). Seven patients had extra-cutaneous involvement: four with peripheral neuropathy and three with interstitial pneumonia. The mean follow-up time was 9 years. Four patients improved: two experienced partial remission and two complete remission. Complete remission was obtained under treatment with dexamethasone (one patient) and thalidomide (one patient). One patient presented a myeloma and one patient presented encephalopathy leading to death.

DISCUSSION

our study shows the frequency of extra-cutaneous involvement and shows that complete remission occurs in some patients.

摘要

背景

硬化性黏液水肿的特征是皮肤黏蛋白沉积伴单克隆丙种球蛋白病。这是一种罕见疾病,大多作为散发病例报道。关于该疾病的病程和预后的数据有限。本研究的目的是确定硬化性黏液水肿的临床特征和病程。

患者与方法

这是一项对1987年至2007年间来自法国五所大学医院患者的回顾性研究。使用标准化问卷收集数据。纳入标准基于Rongioletti和Rebora提出的疾病诊断标准:(1)全身性、丘疹性和硬皮病样皮疹;(2)真皮内黏蛋白沉积、成纤维细胞增殖和皮肤纤维化;(3)存在单克隆丙种球蛋白病;(4)无甲状腺疾病。

结果

纳入8例患者。疾病发病的平均年龄为51.5岁(范围:35 - 67岁)。从主要症状出现到诊断的平均时间为41.6个月(范围:4 - 120个月)。7例患者有皮肤外受累:4例有周围神经病变,3例有间质性肺炎。平均随访时间为9年。4例患者病情改善:2例部分缓解,2例完全缓解。地塞米松(1例患者)和沙利度胺(1例患者)治疗后获得完全缓解。1例患者出现骨髓瘤,1例患者出现脑病并导致死亡。

讨论

我们的研究显示了皮肤外受累的频率,并表明一些患者出现了完全缓解。

相似文献

1
[Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study].[硬化性黏液水肿的临床特征及转归:一项回顾性多中心研究]
Ann Dermatol Venereol. 2010 Dec;137(12):782-8. doi: 10.1016/j.annder.2010.08.011. Epub 2010 Sep 28.
2
[Scleromyxedema].[硬化性黏液水肿]
Hautarzt. 2006 Apr;57(4):326-7. doi: 10.1007/s00105-006-1113-z.
3
[Efficacy of intravenous immunoglobulin in the treatment of scleromyxoedema].静脉注射免疫球蛋白治疗硬化性黏液水肿的疗效
Ann Dermatol Venereol. 2010 Jan;137(1):48-52. doi: 10.1016/j.annder.2009.11.010. Epub 2009 Dec 29.
4
[Response to thalidomide in scleromyxedema].[沙利度胺治疗硬肿病的疗效]
Medicina (B Aires). 2013;73(3):252-4.
5
[Atypical papular mucinosis with initial histological findings evocative of granuloma annulare].[具有最初组织学表现提示环状肉芽肿的非典型丘疹性黏蛋白病]
Ann Dermatol Venereol. 2012 Jan;139(1):58-62. doi: 10.1016/j.annder.2011.10.404. Epub 2011 Dec 6.
6
Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.沙利度胺和地塞米松联合自体干细胞移植治疗硬化性黏液水肿
Rheumatology (Oxford). 2011 Oct;50(10):1925-6. doi: 10.1093/rheumatology/ker209. Epub 2011 Jun 29.
7
Scleromyxedema: successful treatment with thalidomide in two patients.硬化性黏液水肿:沙利度胺成功治疗两例患者
Dermatology. 2007;214(1):58-60. doi: 10.1159/000096914.
8
[Internal disease findings in Arndt-Gottron scleromyxedema].[阿恩特-戈特龙硬皮黏液水肿的内科疾病表现]
Dtsch Med Wochenschr. 1986 May 23;111(21):820-3. doi: 10.1055/s-2008-1068538.
9
[The monoclonal gammapathy of uncertain meaning- a premyelomatosis?].意义未明的单克隆丙种球蛋白病——一种骨髓瘤前期?
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(3):312-6.
10
New strategies for MGUS and smoldering multiple myeloma.意义未明的单克隆丙种球蛋白病和冒烟型多发性骨髓瘤的新策略。
Clin Adv Hematol Oncol. 2004 Aug;2(8):507, 509.

引用本文的文献

1
[Scleromyxedema].[硬化性黏液水肿]
Dermatologie (Heidelb). 2024 Mar;75(3):225-231. doi: 10.1007/s00105-024-05303-0. Epub 2024 Feb 16.
2
New insights on scleromyxedema.硬皮病性黏液水肿的新见解。
J Scleroderma Relat Disord. 2019 Jun;4(2):118-126. doi: 10.1177/2397198318824929. Epub 2019 Jan 29.
3
Myopathy and scleromyxedema.肌病和硬皮黏液水肿。
J Neurol. 2019 Aug;266(8):2051-2059. doi: 10.1007/s00415-019-09379-w. Epub 2019 May 21.
4
[Scleromyxedema].[硬化性黏液水肿]
Hautarzt. 2018 Nov;69(11):916-921. doi: 10.1007/s00105-018-4257-8.
5
Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone.无副蛋白血症的硬化性黏液水肿:沙利度胺和泼尼松龙治疗
Case Rep Dermatol. 2016 Nov 21;8(3):327-332. doi: 10.1159/000452319. eCollection 2016 Sep-Dec.
6
Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy.硬肿性黏液水肿中特定的淋巴结受累:高代谢性淋巴结病的一个新的诊断实体。
Virchows Arch. 2013 Jun;462(6):679-83. doi: 10.1007/s00428-013-1424-2. Epub 2013 May 17.
7
[Scleromyxedema. A chronic progressive systemic disease].[硬化性黏液水肿。一种慢性进行性全身性疾病]
Z Rheumatol. 2012 Aug;71(6):504-14. doi: 10.1007/s00393-012-0997-5.